Human medicines European public assessment report (EPAR): Drovelis, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 8, Status: Authorised
Q&A clinic on web-based electronic Application Form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 11:00 (CET) to 6 March 2025, 11:30 (CET)
Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn
Human medicines European public assessment report (EPAR): Mycapssa, octreotide, Date of authorisation: 02/12/2022, Status: Withdrawn
Release notes - production release version 1.7.2514-3 - 21 March 2025 - Veterinary Medical Products Regulation: Union Product Database
Mandate, objectives and rules of procedure for the CVMP Pharmacovigilance Working Party (PhVWP-V)
2024 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
PSUSA/00000329/202407
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Scintimun, besilesomab, Date of authorisation: 11/01/2010, Revision: 8, Status: Authorised